drugset / Trial / NCT00935493
Guanfacine Treatment for Prefrontal Cognitive Dysfunction in Elderly Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This proposal aims to determine whether low does of the alpha-2A-adrenoceptor agonist guanfacine can improve deficits in prefrontally-mediated cognitive functions in healthy elderly subjects.
Timeline
- Start
- 2009-06
- Primary completion
- 2012-08
- Completion
- 2012-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Guanfacine | Small molecule | 0.1 mg | Oral |
| Subject | Guanfacine | Small molecule | 0.5 mg | Oral |
Indications
No indication recorded.